CROI 2024 - CROI 2024

Symposium: Living Into Young Adulthood With Perinatal HIV

"Discussion with Audience Questions and Answers" by Allison L. Agwu Johns Hopkins University

Victor Reyes Howard University, Washington, DC, USA

Symposium: Living Into Young Adulthood With Perinatal HIV

"Epidemiology of Perinatally Acquired HIV Among Adolescents and Young Adults" by Mutsawashe F. Bwakura-Dangarembizi University of Zimbabwe, Harare, Zimbabwe

Symposium: Living Into Young Adulthood With Perinatal HIV

"Historic Evolution of HIV and Mental Well-Being Among Adults Living With Perinatally Acquired HIV" by Ezer Kang Howard University, Washington, DC, USA

Symposium: Living Into Young Adulthood With Perinatal HIV

"Cardiometabolic Risks and Complications: Adolescents and Young Adults With Perinatally Acquired HIV" by Sahera Dirajlal-Fargo Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA

Symposium: The HIV Vaccine Journey: Don't Stop Believin'

"Discussion with Audience Questions and Answers" by Georgia D. Tomaras Duke University, Durham, NC, USA

Leonidas Stamatatos Fred Hutchison Cancer Center, Seattle, WA, USA

Symposium: The HIV Vaccine Journey: Don't Stop Believin'

"Neutralizing Antibody Protection: Where Do We Go From Here?" by Yunda Huang Fred Hutchison Cancer Center, Seattle, WA, USA

Symposium: The HIV Vaccine Journey: Don't Stop Believin'

"Germline Targeting Strategies to Get On the Road Again" by Rogier W. Sanders Academic Medical Center, Amsterdam, Netherlands

Symposium: The HIV Vaccine Journey: Don't Stop Believin'

"Novel Immunization Strategies to Move on Down the Road" by Darrell Irvine Massachusetts Institute of Technology, Cambridge, MA, USA

Symposium: The Return of Syphilis

"Discussion with Audience Questions and Answers" by Jodie A. Dionne University of Alabama at Birmingham, Birmingham, AL, USA

Alex de Voux University of Cape Town, Cape Town, South Africa

Symposium: The Return of Syphilis

"Why Can't We Do Better at Diagnosing Syphilis?" by Ina Park University of California San Francisco, San Francisco, CA, USA

Symposium: The Return of Syphilis

"The Burgeoning Epidemic of Congenital Syphilis" by Angelica Espinosa Miranda Ministry of Health, Brasilia, Brazil

Symposium: The Return of Syphilis

"Syphilis Management Conundrums" by Khalil G. Ghanem The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Symposium: Impact on HIV Care and Services Among Refugees, Displaced Persons, and Marginalized Populations

"Overview of the Global Displacement Crisis" by Mesfin Teklu Tessema International Rescue Committee

"Panelist Reflections on the Global Displacement Crisis" by

"Meeting the Needs of People Affected by HIV From Ukraine" by Milosz Parczewski Pomeranian Medical University, Szczecin, Poland

"Protracted Consequences of Displacement: A Perspective From Latin America" by Omar M. Sued Pan American Health Organization, Washington, DC, USA

"Lived Experience From Ukraine" by Yana Panfilova Teenergizer, Kyiv, Ukraine

"Roundtable Discussion" by Wafaa El-Sadr Columbia University, New York, NY, USA

"Roundtable Discussion" by Mesfin Teklu Tessema International Rescue Committee

"Roundtable Discussion" by Carlos del Rio Emory University, Atlanta, GA, USA

"Roundtable Discussion" by Milosz Parczewski Pomeranian Medical University, Szczecin, Poland

"Roundtable Discussion" by Yana Panfilova Teenergizer, Kyiv, Ukraine

"Roundtable Discussion" by Omar M. Sued Pan American Health Organization, Washington, DC, USA

Symposium: New Frontiers in Hepatitis B

"Novel Markers of Hepatitis B: Clinical Utility for New Treatment Strategies" by Fabien Zoulim L’Université Claude Bernard Lyon 1, Lyon, France

Symposium: New Frontiers in Hepatitis B

"Advances in HBV Immunotherapy: The Beginning of the End?" by Adam Gehring University of Toronto, Toronto, Canada

Symposium: New Frontiers in Hepatitis B

"How New WHO Guidance Can Transform Hepatitis B in Sub-Saharan Africa" by Olufunmilayo Lesi World Health Organization, Geneva, Switzerland

Symposium: New Frontiers in Hepatitis B

"International Perspectives on Hepatitis B: Panel Discussion" by David L. Thomas The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Weston Spurr Person with Lived Experience, Denver, Colorado

Anna S. Lok University of Michigan, Ann Arbor, MI, USA

Fabien Zoulim L’Université Claude Bernard Lyon 1, Lyon, France

Chien-Ching Hung National Taiwan University Hospital, Taipei City, Taiwan

Hugo Perazzo Oswaldo Cruz Foundation - Fiocruz, Rio de Janeiro, Brazil

Olufunmilayo Lesi World Health Organization, Geneva, Switzerland

Symposium: Not Just a Pretty Shape: HIV Assembly to Disassembly

"Discussion with Audience Questions and Answers" by Owen Pornillos University of Utah, Salt Lake City, UT, USA

Melissa Kane University of Pittsburgh, Pittsburgh, PA, USA

Symposium: Not Just a Pretty Shape: HIV Assembly to Disassembly

"HIV-1 Genome Packaging During Virion Assembly: Selecting the Right RNA" by Wei-Shau Hu National Cancer Institute, Frederick, MD, USA

Symposium: Not Just a Pretty Shape: HIV Assembly to Disassembly

"Virion Maturation: Folding Into the Right Shape" by Mamuka Kvaratskhelia University of Colorado, Aurora, CO, USA

Symposium: Not Just a Pretty Shape: HIV Assembly to Disassembly

"Virion Disassembly: Keeping it Together Until the Right Moment" by Gregory Towers University College London, London, UK

Symposium: Roundtable on DoxyPEP: Ready or Not…

"Discussion with Audience Questions and Answers" by Kenneth Ngure Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya

Michael Traeger Burnet Institute, Melbourne, VIC, Australia

Symposium: Roundtable on DoxyPEP: Ready or Not…

"Introduction to DoxyPEP: Understanding the Issues" by Chase A. Cannon University of Washington, Seattle, WA, USA

Symposium: Roundtable on DoxyPEP: Ready or Not…

"DoxyPEP: Should We Worry About Antimicrobial Resistance?" by Beatrice B.S.L. Bercot St Louis Hospital, Paris, France

Symposium: Roundtable on DoxyPEP: Ready or Not…

"Implementation of DoxyPEP: Challenges and Opportunities" by Stephanie E. Cohen San Francisco Department of Public Health, San Francisco, CA, USA

Symposium: Follow Your Heart: Managing Cardiovascular Disease Risk in HIV

"Overview of the REPRIEVE Trial" by Steven K. Grinspoon Massachusetts General Hospital, Boston, MA, USA

Symposium: Follow Your Heart: Managing Cardiovascular Disease Risk in HIV

"Sex Differences in Atherosclerotic CVD Risks and Mechanisms: Insights From REPRIEVE" by Markella V. Zanni Massachusetts General Hospital, Boston, MA, USA

Symposium: Follow Your Heart: Managing Cardiovascular Disease Risk in HIV

"Immunomodulation and Cardiovascular Disease: Lessons Learned From HIV" by Priscilla Y. Hsue University of California San Francisco, San Francisco, CA, USA

Symposium: Follow Your Heart: Managing Cardiovascular Disease Risk in HIV

"Implications for Implementing CVD Risk Prevention Strategies for Low- and Middle-Income Countries" by Mpiko Ntsekhe University of Cape Town, Cape Town, South Africa

Symposium: Follow Your Heart: Managing Cardiovascular Disease Risk in HIV

"Panel Discussion" by

Symposium: Innovations in Intervention: Toward an HIV Cure

"Discussion with Audience Questions and Answers" by María Buzón Vall d'Hebron Research Institute, Barcelona, Spain

Alberto Bosque George Washington University

Symposium: Innovations in Intervention: Toward an HIV Cure

"From Mechanisms to Therapeutics: Eliminating HIV-Infected Cells by the CARD8 Inflammasome" by Liang Shan Washington University in St Louis, St Louis, MO, USA

Symposium: Innovations in Intervention: Toward an HIV Cure

"From Mechanisms to Therapeutics: TACK Molecules Kill HIV-Infected Cells Through Inflammasome Activation" by Tracy L. Diamond Merck & Co., Inc., Rahway, NJ, USA

Symposium: Innovations in Intervention: Toward an HIV Cure

"From Transcriptomics to Therapeutics: A Host Restriction Factor That Targets HIV Expression" by Rasmi Thomas Walter Reed Army Institute of Research, Silver Spring, MD, USA

Symposium: Innovations in Intervention: Toward an HIV Cure

"From Structure to Therapeutics: CD4 Mimetics 'Open' Env and Sensitize HIV-1-Infected Cells to ADCC" by Andrés Finzi Université de Montréal, Montreal, Canada

Symposium: Promise and Pitfalls of Biomedical Prevention: Beyond Phase III

"Introduction" by Linda-Gail Bekker Desmond Tutu HIV Foundation, Cape Town, South Africa

Bruno Spire Institut National de la Santé et de la Recherche Médicale, Marseille, France

Symposium: Promise and Pitfalls of Biomedical Prevention: Beyond Phase III

"Why Is Cabotegravir Rollout So Slow?" by Rupa R. Patel Centers for Disease Control and Prevention, Atlanta, GA, USA

Symposium: Promise and Pitfalls of Biomedical Prevention: Beyond Phase III

"The Ring Comes Full Circle: Navigating the Complex Landscape of Biomedical Prevention Post-Phase III" by Leila E. Mansoor Centre for the AIDS Programme of Research in South Africa, Durban, South Africa

Symposium: Promise and Pitfalls of Biomedical Prevention: Beyond Phase III

"Challenging the Dogma of Event-Driven PrEP" by Jenell Stewart Hennepin Healthcare Research Institute, Minneapolis, MN, USA

Symposium: Promise and Pitfalls of Biomedical Prevention: Beyond Phase III

"Panel Discussion" by Linda-Gail Bekker Desmond Tutu HIV Foundation, Cape Town, South Africa

Bruno Spire Institut National de la Santé et de la Recherche Médicale, Marseille, France